<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kuwano T</submitter><funding>Japan Agency for Medical Research and Development</funding><pagination>26057</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11522698</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>There have been several reports of skin manifestations in patients with coronavirus disease 2019 (COVID-19). However, it is unclear whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA can be detected on the skin surface, including the sebum, of these patients. In this study, SARS-CoV-2 RNA was detected using real-time reverse-transcription polymerase chain reaction (RT-PCR) assay of skin surface lipids (SSLs) collected using an oil-blotting film from the faces of hospitalized patients with COVID-19. Human transcriptome analysis was also performed using the same samples. In facial SSLs of patients with COVID-19, the RT-PCR positivity rate was 84.6% (11/13 samples) within 5 days and 30.4% (7/23 samples) by 6-10 days of symptom onset. In the transcriptome analysis, the mo</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Non-invasive SARS-CoV-2 RNA detection and human transcriptome analysis using skin surface lipids.</pubmed_title><pmcid>PMC11522698</pmcid><funding_grant_id>JP21fk0108104</funding_grant_id><pubmed_authors>Nagai H</pubmed_authors><pubmed_authors>Suzuki T</pubmed_authors><pubmed_authors>Tsutsumi T</pubmed_authors><pubmed_authors>Kawana-Tachikawa A</pubmed_authors><pubmed_authors>Kuwano T</pubmed_authors><pubmed_authors>Yotsuyanagi H</pubmed_authors><pubmed_authors>Iwamura M</pubmed_authors><pubmed_authors>Fukushima K</pubmed_authors><pubmed_authors>Kobayashi T</pubmed_authors><pubmed_authors>Koga M</pubmed_authors><pubmed_authors>Miyazato Y</pubmed_authors><pubmed_authors>Tobiume M</pubmed_authors><pubmed_authors>Imamura A</pubmed_authors><pubmed_authors>Kanno T</pubmed_authors><pubmed_authors>Kutsuna S</pubmed_authors><pubmed_authors>Tanaka M</pubmed_authors><pubmed_authors>Kinoshita-Iwamoto N</pubmed_authors><pubmed_authors>Inoue T</pubmed_authors><pubmed_authors>Matano T</pubmed_authors><pubmed_authors>Yoshikawa N</pubmed_authors><pubmed_authors>Ueda Y</pubmed_authors><pubmed_authors>Hirata Y</pubmed_authors><pubmed_authors>Ohmagari N</pubmed_authors><pubmed_authors>Takada N</pubmed_authors><pubmed_authors>Katano H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Non-invasive SARS-CoV-2 RNA detection and human transcriptome analysis using skin surface lipids.</name><description>There have been several reports of skin manifestations in patients with coronavirus disease 2019 (COVID-19). However, it is unclear whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA can be detected on the skin surface, including the sebum, of these patients. In this study, SARS-CoV-2 RNA was detected using real-time reverse-transcription polymerase chain reaction (RT-PCR) assay of skin surface lipids (SSLs) collected using an oil-blotting film from the faces of hospitalized patients with COVID-19. Human transcriptome analysis was also performed using the same samples. In facial SSLs of patients with COVID-19, the RT-PCR positivity rate was 84.6% (11/13 samples) within 5 days and 30.4% (7/23 samples) by 6-10 days of symptom onset. In the transcriptome analysis, the mo</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-07-16T00:21:58.996Z</modification><creation>2025-04-06T23:17:42.673Z</creation></dates><accession>S-EPMC11522698</accession><cross_references><pubmed>39472469</pubmed><doi>10.1038/s41598-024-77862-0</doi></cross_references></HashMap>